Igβ(CD79b)mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Igβ(CD79b)mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity

Published:2007-08 Issue:8 Volume:82 Page:712-720
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Cajiao Isabela,Sargent Rachel,Elstrom Rebecca,Cooke Nancy E.,Bagg Adam,Liebhaber Stephen A.

Publisher

Wiley

Subject

Hematology

Reference55 articles.

1. Cancer statistics;Landis;CA Cancer J Clin,1998

2. Chronic lymphocytic leukaemia an accumulative disease of immunologically incompetent lymphocytes;Dameshek;Blood,1967

3. JaffeES,HarrisNL,SteinH,VardimanJW, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.

4. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b);Zomas;Leukaemia,1996

5. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukaemia;Thompson;Blood,1997

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions;Frontiers in Immunology;2012

2. Chronic Lymphocytic Leukemia and the B-Cell Receptor;Chronic Lymphocytic Leukemia;2008-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP